Guardian Science Weekly

Are we finally nearing a treatment for Alzheimer’s?

Loading player...
Back in November, researchers hailed the dawn of a new era of Alzheimer’s therapies. After decades of failure, a clinical trial finally confirmed that a drug, lecanemab, was able to slow cognitive decline in patients with early stages of the disease. The result may have been modest – a reduction in the decline in patients’ overall mental skills by 27% over 18 months – but it could not be more significant in the journey towards better understanding and treating the disease. Ian Sample speaks to Prof Nick Fox about the clinical trial results, if this could be the first of many new Alzheimer’s therapies, and whether we could one day see a cure.. Help support our independent journalism at theguardian.com/sciencepod
28 Dec 2022 English United Kingdom Science · Nature

Other recent episodes

Shrinking states: a positive future with fewer people?

The fertility rate in England and Wales has fallen for the third year in a row – a trend mirrored across the world, with two-thirds of the global population now living in countries with below-replacement-level fertility. In the second episode of a two-part series, Madeleine Finlay speaks to Dean Spears,…
10 Sep 16 min

Shrinking states: are we on a path to depopulation?

The fertility rate in England and Wales has fallen for the third year in a row. It is a story that is being repeated all over the world, with two thirds of the global population now living in countries with below replacement level fertility. Low fertility rates have become a…
8 Sep 19 min

Is curiosity the key to ageing well?

Psychologists have traditionally believed we become less curious as we age, but recent research has shown that curiosity actually becomes more targeted and specific in our later years. To find out why this happens, and how maintaining broad curiosity into older age can help keep our brains young, Madeleine Finlay…
3 Sep 16 min

RFK Jr and the chaos at the CDC

It’s been a dramatic week at the US Centres for Disease Control and Prevention (CDC). In the space of seven days, the agency’s head was sacked and replaced by an interim head, four senior staff members resigned, and existing staff took to the streets to express support for their ousted…
1 Sep 17 min

‘AI psychosis’: could chatbots fuel delusional thinking?

There are increasing reports of people experiencing delusions after intensive use of AI chatbots. The phenomenon, dubbed ‘AI psychosis’, has raised concerns that features built into large language models may contribute to some users losing touch with reality. Madeleine Finlay speaks to Dr Hamilton Morrin, a psychiatrist and researcher at…
27 Aug 17 min
All episodes